Marianne Westerveld

Marianne Westerveld is a prominent researcher at Erasmus University Medical Center (Erasmus MC) in Rotterdam, Netherlands, specializing in Clinical Genetics. With 54 research publications to her name, she has established herself as a significant contributor to the field of genetic disorders, particularly focusing on mucopolysaccharidoses, neurofibromatosis, and other inherited metabolic conditions.

Her educational background and specific academic appointments are not explicitly detailed in the available information, but her extensive publication record spanning multiple years indicates a well-established academic career at Erasmus MC.

Dr. Westerveld's research interests include:

• Gene therapy for mucopolysaccharidosis type II (Hunter syndrome)
• Enzyme replacement therapies and their mechanisms
• RNA splicing analysis for genetic diagnostics
• Neurodevelopmental disorders and their genetic basis
• Lysosomal storage disorders including Pompe disease
• Variant classification methodologies for neurofibromatosis type 1 and Legius syndrome

Her recent publications (2023-2024) demonstrate a strong focus on translational research, particularly in developing and improving diagnostic methods and therapeutic approaches for rare genetic disorders. Her work often involves collaborative efforts with multiple research groups across different institutions, as evidenced by the extensive author lists on her publications.

Notable contributions include developing web-accessible applications for RNA-seq analysis to improve diagnostic sensitivity for neurodevelopmental disorders and investigating novel gene therapy approaches for mucopolysaccharidosis that target both peripheral tissues and the brain.

While specific scientific awards are not mentioned in the available information, the impact of her work is reflected in the citation metrics of her publications, with some papers accumulating dozens of citations and being featured in blog posts and social media discussions.

Dr. Westerveld appears to be actively involved in both basic research and clinical applications, with her work having direct implications for patient care and diagnostic methodologies in the field of clinical genetics.